
LWAY
Lifeway Foods Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
22.8099
Open
21.510
VWAP
22.12
Vol
240.76K
Mkt Cap
342.65M
Low
21.250
Amount
5.33M
EV/EBITDA(TTM)
18.83
Total Shares
14.71M
EV
319.66M
EV/OCF(TTM)
39.45
P/S(TTM)
1.68
Lifeway Foods, Inc. is a supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the Company also produces a variety of cheeses and a ProBugs line for kids. Its primary product is drinkable kefir, a cultured dairy product. Lifeway kefir is tart and tangy, high in protein, calcium and vitamin D. It manufactures products under the Lifeway, Fresh Made and GlenOaks Farms brand names, as well as under private labels on behalf of certain customers. Its product categories are Drinkable kefir; European-style soft cheeses, including farmer cheese, white cheese, and Sweet Kiss; Cream and others, which consist primarily of cream, a byproduct of making its kefir; Drinkable yogurt, sold in a variety of sizes and flavors; ProBugs, a line of kefir products designed for children; and Other dairy, which consists primarily of Fresh Made butter and sour cream. The Company’s dairy products are sold across the United States, Mexico, and other countries.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
61.00M
+13.17%
0.340
+21.43%
54.00M
+17.16%
0.180
-21.74%
55.00M
+17.19%
0.280
-2900%
Estimates Revision
The market is revising No Change the revenue expectations for Lifeway Foods, Inc. (LWAY) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -29.09%.
Revenue Estimates for FY2025
No Change

0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change

0.00%
In Past 3 Month
Stock Price
Go Down

-29.09%
In Past 3 Month
1 Analyst Rating
Wall Street analysts forecast LWAY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LWAY is 33.00 USD with a low forecast of 33.00 USD and a high forecast of 33.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 22.500
Low
33.00
Averages
33.00
High
33.00
Current: 22.500
Low
33.00
Averages
33.00
High
33.00
Benchmark
Ben Klieve
Buy
initiated
$35
2025-11-13
Reason
Benchmark
Ben Klieve
Price Target
$35
2025-11-13
initiated
Buy
Reason
Benchmark analyst Ben Klieve initiated coverage of Lifeway Foods with a Buy rating and $35 price target. The firm views the company as a "high growth investment opportunity" that remains overlooked by investors. Lifeway 's recent challenges with major shareholders are tempering, which should provide a greater focus on the value proposition of its fundamentals, the analyst tells investors in a research note. Benchmark likes the company's "dominant" market share in a high growth category.
Lake Street
Buy
maintain
$30 -> $33
2025-08-13
Reason
Lake Street
Price Target
$30 -> $33
2025-08-13
maintain
Buy
Reason
Lake Street raised the firm's price target on Lifeway Foods to $33 from $30 and keeps a Buy rating on the shares. The firm's increased target reflects an unchanged multiple applied to its FY26 estimates after the company delivered "healthy" 10% revenue growth and a return of mid-teen EBITDA margins in Q2, the analyst noted. The firm believes Lifeway could approach a peer valuation without the complications from its major owners, but assumes a discounted multiple for the time being until the outcome of the standstill agreement is understood, the analyst added.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Lifeway Foods Inc (LWAY.O) is 17.72, compared to its 5-year average forward P/E of 19.81. For a more detailed relative valuation and DCF analysis to assess Lifeway Foods Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
19.81
Current PE
17.72
Overvalued PE
39.53
Undervalued PE
0.08
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
4.44
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
10.50
Undervalued EV/EBITDA
-1.63
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
0.86
Current PS
0.00
Overvalued PS
1.50
Undervalued PS
0.21
Financials
Annual
Quarterly
FY2025Q3
YoY :
+23.97%
57.14M
Total Revenue
FY2025Q3
YoY :
+20.32%
5.04M
Operating Profit
FY2025Q3
YoY :
+18.58%
3.53M
Net Income after Tax
FY2025Q3
YoY :
+21.05%
0.23
EPS - Diluted
FY2025Q3
YoY :
-70.06%
1.77M
Free Cash Flow
FY2025Q3
YoY :
+11.91%
28.48
Gross Profit Margin - %
FY2025Q3
YoY :
-118.35%
-1.38
FCF Margin - %
FY2025Q3
YoY :
-4.33%
6.18
Net Margin - %
FY2025Q3
YoY :
-27.16%
14.51
ROIC
Trading Trends
Insider
Insiders areSelling! The selling amount has increased 488.43% over the last month.
Sold
0-3
Months
3.0M
USD
5
3-6
Months
595.3K
USD
2
6-9
Months
4.5M
USD
14
0-12
Months
3.0M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 104.35% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
17.4K
Volume
Months
0-12
1
8.5K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areSelling! The selling amount has increased 488.43% over the last month.
Sold
0-3
Months
3.0M
USD
5
3-6
Months
595.3K
USD
2
6-9
Months
4.5M
USD
14
0-12
Months
3.0M
USD
7
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
LWAY News & Events
Events Timeline
2025-11-12 (ET)
2025-11-12
09:06:00
Lifeway Foods confirms adjusted EBITDA forecast of $45M-$50M for FY27
2025-11-12
09:05:06
Lifeway Foods announces Q3 earnings per share of 23 cents, up from 19 cents a year ago.
2025-11-07 (ET)
2025-11-07
10:18:16
Smolyansky urges Lifeway Foods to 'respect' board renewal.
Sign Up For More Events
Sign Up For More Events
News
5.0
11-21PRnewswireKefir-Leader Lifeway Foods Expands Farmer Cheese Distribution to 2,000 Walmart Stores Across the U.S.
4.0
11-14NASDAQ.COMDaily Upgrade Report for Validea's Peter Lynch Strategy - November 14, 2025
9.5
11-12PRnewswireLifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance
Sign Up For More News
People Also Watch

NETD
Nabors Energy Transition Corp II
11.580
USD
+0.61%

TRVI
Trevi Therapeutics Inc
10.990
USD
+3.19%

NMRA
Neumora Therapeutics Inc
2.330
USD
-1.27%

CERS
Cerus Corp
1.620
USD
+8.72%

MBX
MBX Biosciences Inc
27.080
USD
+0.18%

YSG
Yatsen Holding Ltd
6.350
USD
+3.25%

BRT
BRT Apartments Corp
14.360
USD
+2.50%

HBANL
Huntington Bancshares Inc
25.540
USD
+0.24%

CIVB
Civista Bancshares Inc
22.460
USD
+4.61%

ZBIO
Zenas Biopharma Inc
35.800
USD
+2.76%
FAQ
What is Lifeway Foods Inc (LWAY) stock price today?
The current price of LWAY is 22.5 USD — it has increased 4.7 % in the last trading day.





